Downstream

Studies of EV cell uptake are crucial for understanding how extracellular vesicles deliver their cargo and mediate intercellular communication. By tracking EV internalization, researchers can identify the mechanisms, pathways, and factors that influence cellular entry, specificity, and efficiency. These insights are essential for optimizing EV-based therapeutics, improving targeted delivery, and predicting biological outcomes in both physiological and disease contexts.

Despite EVs are of high interest as tunable messengers or drug-carriers, any therapeutic or pharmaceutical application requires to ensure efficient take-up by the target cells. At HansaBioMed, we offer our expertise to monitor EV traffic and track their uptake by the target cell groups.